Chongqing Branch of the People's Bank of China investigates Chongqing Water Environment Group: Support Chongqing Water Environment Group's demands for integration and optimization. Recently, Wenjiang Yong, member of the Party Committee and vice president of Chongqing Branch of the People's Bank of China (Chongqing Branch of the State Administration of Foreign Exchange), and his party visited Chongqing Water Environment Group to conduct in-depth research on the "three challenges and one revitalization" of state-owned enterprise reform deployed by the Municipal Party Committee. He stressed that it is necessary to give full play to the function of foreign exchange management, solve problems for enterprises, and support the related work involving integration and optimization in Chongqing Water Environment Group's "Three Attacks and One Revitalization". At the symposium, Wen Jiangyong and his party listened to Lu Xian's introduction on the basic situation of Chongqing Water Environment Group and the report of the head of Derun Environment Company on the difficulties related to the company's integration and optimization and the matters for support. Wen Jiangyong pointed out that on the basis of grasping the fairness of transactions and the balance of cross-border funds, he will solve problems for enterprises according to specific conditions and support Chongqing Water Environment Group's related demands for integration and optimization. At the same time, in the future work, the two sides should strengthen communication and help enterprises grow and develop.The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.CICC and others set up a venture capital partnership in Xiamen. According to the enterprise search APP, Zhongjin Qiyuan Phase II (Xiamen) Venture Capital Partnership (Limited Partnership) was recently established with a capital contribution of 400 million yuan. Its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the company is jointly held by CICC Capital Operation Co., Ltd., a wholly-owned subsidiary of CICC.
The securities sector continued to rise, and Guolian Securities closed the daily limit. Prior to this, Guosheng Financial Holdings had three consecutive boards, and Harbin Investment, Southwest Securities, Huaxin Shares and Cinda Securities followed suit.China Resources Property Company responded to the explosion of high-rise residential buildings in Shenzhen Bay Yuefu. On December 12, China Resources Property Company responded to the explosion of high-rise residential buildings in Shenzhen Bay Yuefu: Next, the property company will fully cooperate with relevant government departments to do the aftermath, help and care for residents as much as possible, and tide over the difficulties with them.According to the data released by Shanghai Steel Union, the price of battery-grade lithium carbonate (in early trading) was the same as that of the previous day, with an average price of 76,450 yuan/ton.
Yunnan Germanium Industry: downstream customers didn't feedback that the company germanium was directly used in quantum chip products. Some investors asked Yunnan Germanium Industry (002428) on the interactive platform: in quantum computing and quantum communication, germanium is widely used in the manufacturing process of quantum chips, which can achieve excellent performance. Excuse me, does the company have germanium products used in quantum chips? Yunnan Germanium Industry replied that at present, the downstream customers of the company have not reported to the company that it is directly used in this product.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.The United States ITC issued a 337-part final ruling on electronic cigarette oil atomizers and their components and downstream products. According to China Trade Relief Information Network, on December 10th, the United States International Trade Commission (ITC) issued a notice saying that certain electronic cigarette oil atomizers and their components and downstream products (components thereof, And Products Containing the Same (investigation code: 337-TA-1392) made the final ruling of part 337: the preliminary ruling (No.32) made by the administrative judge in this case on November 8, 2024 was not reviewed, that is, the investigation of the following contents in this case was terminated based on the withdrawal of the applicant: U.S. registered patent No.11,369,757, paragraphs 2, 9 and 17. Complaints 23, 26 and 30 of U.S. Patent No.11,766,527 and complaints 11, 16-18 and 20 of U.S. Patent No.11,759,580.
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14